5 things to watch on the ASX 200 next week

CSL Limited (ASX:CSL) and Nearmap Ltd (ASX:NEA) shares will be on watch on the ASX 200 next week. Here's what you need to know…

The S&P/ASX 200 Index (ASX: XJO) was out of form last week and tumbled lower following a mixed bag of results. The benchmark index dropped 0.6% to end the period at 6,806.7 points.

Another busy week lies ahead for investors. Here are five things to watch next week:

hand restin g on laptop computer keyboard with stock prices on screen

Image source: Getty Images

ASX futures pointing notably higher

The Australian share market looks set to start the week on a very positive note. According to the latest SPI futures, the ASX 200 is expected to open the day 37 points higher on Monday morning. This follows a solid finish to the week on Wall Street. On Friday night the Dow Jones rose 0.1%, the S&P 500 climbed 0.5%, and the Nasdaq index also rose 0.5%.

Nearmap short seller response and half year update

On Monday the Nearmap Ltd (ASX: NEA) share price will return from its trading halt. The aerial imagery technology and location data company requested a trading halt on Thursday in order to respond to a short seller attack. Hong Kong-based J Capital alleges that Nearmap is struggling in the U.S. market and using accounting tricks to hide this. Nearmap intends to bring forward the release of its half year results and release both together.

Mining giants' updates

It will be a big week for the resources sector next week with results due to be released by BHP Group Ltd (ASX: BHP), Fortescue Metals Group Limited (ASX: FMG), and Rio Tinto Limited (ASX: RIO). Thanks to the sky high iron ore price, all three are tipped to deliver bumper profits and pay big dividends to shareholders. BHP is reporting on Tuesday, Rio Tinto is on Wednesday, and Fortescue will release its results on Thursday.

CSL half year results

The CSL Limited (ASX: CSL) share price will be on watch when it releases its highly anticipated half year results on Thursday. According to CommSec, the biotech giant is expected to report a net profit after tax of US$1.4 billion and declare an interim dividend of 97 U.S. cents. All eyes will on its outlook and particularly its comments regarding challenging plasma collections because of COVID-19. As plasma is a vital ingredient in many key therapies, there are concerns that input costs could rise and weigh on margins.

Coles update

On Wednesday the Coles Group Ltd (ASX: COL) share price could be on the move when it releases its half year results. According to a note out of Goldman Sachs, its analysts are expecting Coles to report group sales of $20,585.9 million for the half. This will be an increase of 9.2% on the prior corresponding period. And on the bottom line, the broker is forecasting a 10.5% increase in underlying net profit after tax to $540.4 million. This is expected to lead to an interim dividend of 34 cents per share being declared.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Nearmap Ltd. The Motley Fool Australia owns shares of COLESGROUP DEF SET. The Motley Fool Australia has recommended Nearmap Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A woman weraing a stripy t-shirt winks as she points to the decorative gold crown on her head.
ASX Share Market News

CBA shares back on top of the ASX 200 as BHP dives 13% this week

CBA shares have rallied 9.5% over the past month whilst BHP tumbled 13% this week.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

2 ASX shares tipped to grow up to 122% in the next 12 months

These companies could be on the cusp of something big.

Read more »